SCHEMBL409272

SCHEMBL409272

CC1C[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10871904 1.00
SCHEMBL3496163 0.91
SCHEMBL10845335 0.78
SCHEMBL11221604 0.75
SCHEMBL1547282 0.75
SCHEMBL5868662 0.73
SCHEMBL10475086 0.73
SCHEMBL10473674 0.73
SCHEMBL1860411 0.73
SCHEMBL1568924 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024094125-A1 LIPID COMPOUNDS, LIPID NANOPARTICLES, AND PHARMACEUTICAL COMPOSITIONS Shanghai Circode Biomed Co., Ltd. (CN) 2024-05-10 WO claimed
WO-2021062557-A1 CANNABINOID DERIVATIVES CANOPY GROWTH CORPORATION (CA) 2021-04-08 WO claimed
WO-2021062559-A1 CANNABINOID DERIVATIVES CANOPY GROWTH CORPORATION (CA) 2021-04-08 WO claimed
EP-3504277-B1 COMPOSITE MATERIALS BASF SE (DE) 2020-10-07 EP claimed
EP-2935247-B1 PRMT5 INHIBITORS AND USES THEREOF EPIZYME INC (US) 2019-08-28 EP claimed
EP-2935243-B1 PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF EPIZYME INC (US) 2018-03-14 EP claimed
US-9603829-B2 HSP90 inhibitors with modified toxicity THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2017-03-28 US claimed
US-20150361042-A1 PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2015-12-17 US claimed
US-20150344433-A1 PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF Epizyme, Inc. (US) 2015-12-03 US claimed
EP-2935243-A1 PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF Epizyme, Inc. (US) 2015-10-28 EP claimed
EP-1863769-A4 HSP90 INHIBITORS, METHODS OF MAKING AND USES THEREFOR UNIV COLORADO (US) 2009-03-18 EP claimed
WO-2009026548-A1 HSP90 INHIBITORS WITH MODIFIED TOXICITY THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2009-02-26 WO claimed
EP-1863769-A2 HSP90 INHIBITORS, METHODS OF MAKING AND USES THEREFOR The Board of Regents of the University of Colorado (US) 2007-12-12 EP claimed
WO-2006098761-A2 HSP90 INHIBITORS, METHODS OF MAKING AND USES THEREFOR THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2006-09-21 WO claimed
US-20060205705-A1 Hsp90 inhibitors, methods of making and uses therefor UNIVERSITY OF COLORADO (US) 2006-09-14 US claimed
WO-2002034742-A1 AZIRIDINYLQUINOLINEDIONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2002-05-02 WO claimed
WO-1997023456-A1 INDOLOQUINONE DERIVATIVES AS BIOREDUCTIVE AGENTS BRITISH TECHNOLOGY GROUP LTD. (GB) 1997-07-03 WO claimed
EP-0494005-B1 Multicomponent agent or kit for the preparation of the sulphoconjugated forms of pyridino-, pyrimidino- or triazino-N-oxyde compounds and method of application thereof OREAL (FR) 1997-02-05 EP claimed
EP-0494005-A1 Multicomponent agent or kit for the preparation of the sulphoconjugated forms of pyridino-, pyrimidino- or triazino-N-oxyde compounds and method of application thereof L'OREAL (FR) 1992-07-08 EP claimed
EP-0158874-B1 CURABLE IMINATED RESINS FROM AMINOPLASTS AND HYDROXYLCONTAINING CARBOXYLIC ACIDS PPG INDUSTRIES, INC. (US) 1988-06-08 EP claimed